Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Charles Mesguich

Advanced Hodgkin’s Lymphoma: End-Of-Treatment FDG-PET Should Be Maintained

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2017English

Related publications

Fact Sheet About Interim and End-Of-Treatment 18 F-FDG PET/CT in Lymphoma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

Hodgkin Lymphoma: Is There Really a Need for Interim and End-Of-Treatment FDG-PET Evaluations?

British Journal of Haematology
Hematology
2016English

Reply: Fact Sheet About Interim and End-Of-Treatment 18 F-FDG PET/CT in Lymphoma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

FDG PET/CT Leads to the Detection of Metastatic Involvement of the Heart in Non-Hodgkin’s Lymphoma

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2011English

Unproven Value of End-Of-Treatment and Serial Follow-Up FDG-PET in Primary Mediastinal B-Cell Lymphoma

Haematologica
Hematology
2018English

FDG-PET Scan in Lymphoma: Silver Anniversary

Clinical and Translational Imaging
Nuclear MedicineRadiologyImaging
2015English

FDG PET in Response Evaluation of Bulky Masses in Paediatric Hodgkin’s Lymphoma (HL) Patients Enrolled in the Italian AIEOP-LH2004 Trial

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2018English

Interim FDG-PET Has No Value in Selecting Patients Who Require Treatment Modification in Both Early- And Advanced-Stage Hodgkin Lymphoma

British Journal of Haematology
Hematology
2017English

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy